Small Interfering RNA (siRNA)
All Product Categories
-
Small Interfering RNA (siRNA) Related Products (29620)
Related Products (29620)
-
EGR2 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS04216EGR2 Human Pre-designed siRNA Set A contains three designed siRNAs for EGR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
SLC7A5 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS13331SLC7A5 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC7A5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
GLDC Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS05468GLDC Human Pre-designed siRNA Set A contains three designed siRNAs for GLDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
GPT Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS05762GPT Human Pre-designed siRNA Set A contains three designed siRNAs for GPT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
PGAM5 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS10376PGAM5 Human Pre-designed siRNA Set A contains three designed siRNAs for PGAM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
UPF1 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS15482UPF1 Human Pre-designed siRNA Set A contains three designed siRNAs for UPF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
SLC1A5 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS13056SLC1A5 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC1A5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
RUNX3 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS12352RUNX3 Human Pre-designed siRNA Set A contains three designed siRNAs for RUNX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
Camp Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS16241Camp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Camp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
EPAS1 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS04409EPAS1 Human Pre-designed siRNA Set A contains three designed siRNAs for EPAS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
VCP Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS15621VCP Human Pre-designed siRNA Set A contains three designed siRNAs for VCP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
FTO Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS05136FTO Human Pre-designed siRNA Set A contains three designed siRNAs for FTO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
BRCA1 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS01593BRCA1 Human Pre-designed siRNA Set A contains three designed siRNAs for BRCA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
CREB1 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS03148CREB1 Human Pre-designed siRNA Set A contains three designed siRNAs for CREB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
VDR Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS15632VDR Human Pre-designed siRNA Set A contains three designed siRNAs for VDR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
Braxlosiran
0 ImagesCat. No.: HY-177971Braxlosiran is a component of the AOC reagent Delpacibart braxlosiran (HY-177566), consisting of an siRNA targeting DUX4 (double homeobox protein) and SMCC linker (HY-42360). Delpacibart braxlosiran binds to TfR1. Aberrant expression of the DUX4 protein causes changes in gene expression in muscle cells, which are associated with muscle function loss in facioscapulohumeral muscular dystrophy (FSHD).
